RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,656 | -54.1% | 581 | -48.3% | 0.00% | – |
Q2 2023 | $21,018 | +1.9% | 1,124 | 0.0% | 0.00% | – |
Q1 2023 | $20,625 | +91.8% | 1,124 | +107.0% | 0.00% | – |
Q4 2022 | $10,751 | -17.3% | 543 | 0.0% | 0.00% | – |
Q3 2022 | $13,000 | -96.0% | 543 | -94.6% | 0.00% | -100.0% |
Q3 2020 | $325,000 | – | 10,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $35,171,000 | 45.66% |
KPCB XV Associates, LLC | 1,297,063 | $28,522,000 | 36.91% |
Ponoi II Management, LLC | 145,401 | $3,197,000 | 7.10% |
Column Group LLC | 1,402,008 | $30,830,000 | 5.72% |
Euclidean Capital LLC | 432,900 | $9,519,000 | 5.53% |
AJU IB Investment Co., Ltd. | 99,503 | $2,188,000 | 3.38% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,088,321 | $23,932,000 | 2.49% |
Velan Capital Investment Management LP | 110,000 | $2,419,000 | 2.24% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $9,755,000 | 1.46% |
Perceptive Advisors | 2,799,962 | $61,571,000 | 1.23% |